INVOKANA

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, UK.

Active ingredients

The drug INVOKANA contains one active pharmaceutical ingredient (API):

1	Canagliflozin UNII 0SAC974Z85 - CANAGLIFLOZIN
	Canagliflozin is an orally-active inhibitor of SGLT2. The SGLT2 transporter, expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. By inhibiting SGLT2, canagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose (RTG).
	Read more about Canagliflozin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INVOKANA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BK02		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	514514110027102, 514514110027202, 514514110027302, 514514110027402
CA	Health Products and Food Branch	02425483, 02425491
EE	Ravimiamet	1633407, 1633418, 1633429, 1633430, 1633441, 1633452, 1633463, 1633474
ES	Centro de información online de medicamentos de la AEMPS	113884002, 113884006
FI	Lääkealan turvallisuus- ja kehittämiskeskus	129010, 135362, 458746, 547129
FR	Base de données publique des médicaments	64292898, 67448256
GB	Medicines & Healthcare Products Regulatory Agency	240884, 240887, 376671, 379898, 381410
HK	Department of Health Drug Office	63499, 63500, 66454, 66455
IE	Health Products Regulatory Authority	13489, 13490, 29007, 47851, 47858
IT	Agenzia del Farmaco	043145010, 043145022, 043145034, 043145046, 043145059, 043145061, 043145073, 043145085
LT	Valstybinė vaistų kontrolės tarnyba	1072119, 1072120, 1072121, 1072122
NL	Z-Index G-Standaard, PRK	115398, 115401
PL	Rejestru Produktów Leczniczych	100306753, 100306782
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60447001, W60447002, W60447003, W60447004, W60448001, W60448002, W60448003, W60448004
SG	Health Sciences Authority	14506P, 14507P
US	FDA, National Drug Code	50090-4364, 50090-5033, 50090-5034, 50458-140, 50458-141, 55154-1425, 55154-1426